164 related articles for article (PubMed ID: 21886786)
1. Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer.
Jain M; Venkatraman G; Moniaux N; Kaur S; Kumar S; Chakraborty S; Varshney GC; Batra SK
PLoS One; 2011; 6(8):e23344. PubMed ID: 21886786
[TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of anti-MUC4 monoclonal antibodies reactive with normal and cancer cells in humans.
Moniaux N; Varshney GC; Chauhan SC; Copin MC; Jain M; Wittel UA; Andrianifahanana M; Aubert JP; Batra SK
J Histochem Cytochem; 2004 Feb; 52(2):253-61. PubMed ID: 14729877
[TBL] [Abstract][Full Text] [Related]
3. Alternate splicing at the 3'-end of the human pancreatic tumor-associated mucin MUC4 cDNA.
Choudhury A; Moniaux N; Ringel J; King J; Moore E; Aubert JP; Batra SK
Teratog Carcinog Mutagen; 2001; 21(1):83-96. PubMed ID: 11135323
[TBL] [Abstract][Full Text] [Related]
4. A Tumor-Selective Monoclonal Antibody from Immunization with a Tumor-Associated Mucin Glycopeptide.
Trabbic KR; Whalen K; Abarca-Heideman K; Xia L; Temme JS; Edmondson EF; Gildersleeve JC; Barchi JJ
Sci Rep; 2019 Apr; 9(1):5662. PubMed ID: 30952968
[TBL] [Abstract][Full Text] [Related]
5. Antibody induction directed against the tumor-associated MUC4 glycoprotein.
Cai H; Palitzsch B; Hartmann S; Stergiou N; Kunz H; Schmitt E; Westerlind U
Chembiochem; 2015 Apr; 16(6):959-67. PubMed ID: 25755023
[TBL] [Abstract][Full Text] [Related]
6. Human MUC4 mucin induces ultra-structural changes and tumorigenicity in pancreatic cancer cells.
Moniaux N; Chaturvedi P; Varshney GC; Meza JL; Rodriguez-Sierra JF; Aubert JP; Batra SK
Br J Cancer; 2007 Aug; 97(3):345-57. PubMed ID: 17595659
[TBL] [Abstract][Full Text] [Related]
7. Characterization of recombinant β subunit of human MUC4 mucin (rMUC4β).
Kshirsagar PG; Gulati M; Junker WM; Aithal A; Spagnol G; Das S; Mallya K; Gautam SK; Kumar S; Sorgen P; Pandey KK; Batra SK; Jain M
Sci Rep; 2021 Dec; 11(1):23730. PubMed ID: 34887447
[TBL] [Abstract][Full Text] [Related]
8. Human MUC4 mucin cDNA and its variants in pancreatic carcinoma.
Choudhury A; Moniaux N; Winpenny JP; Hollingsworth MA; Aubert JP; Batra SK
J Biochem; 2000 Aug; 128(2):233-43. PubMed ID: 10920259
[TBL] [Abstract][Full Text] [Related]
9. Alternative splicing generates a family of putative secreted and membrane-associated MUC4 mucins.
Moniaux N; Escande F; Batra SK; Porchet N; Laine A; Aubert JP
Eur J Biochem; 2000 Jul; 267(14):4536-44. PubMed ID: 10880978
[TBL] [Abstract][Full Text] [Related]
10. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells.
Chaturvedi P; Singh AP; Chakraborty S; Chauhan SC; Bafna S; Meza JL; Singh PK; Hollingsworth MA; Mehta PP; Batra SK
Cancer Res; 2008 Apr; 68(7):2065-70. PubMed ID: 18381409
[TBL] [Abstract][Full Text] [Related]
11. The membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cells.
Workman HC; Miller JK; Ingalla EQ; Kaur RP; Yamamoto DI; Beckett LA; Young LJ; Cardiff RD; Borowsky AD; Carraway KL; Sweeney C; Carraway KL
Breast Cancer Res; 2009; 11(5):R70. PubMed ID: 19761616
[TBL] [Abstract][Full Text] [Related]
12. Presence of MUC4 in human milk and at the luminal surfaces of blood vessels.
Zhang J; Perez A; Yasin M; Soto P; Rong M; Theodoropoulos G; Carothers Carraway CA; Carraway KL
J Cell Physiol; 2005 Jul; 204(1):166-77. PubMed ID: 15672420
[TBL] [Abstract][Full Text] [Related]
13. MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.
Tamura Y; Higashi M; Kitamoto S; Yokoyama S; Osako M; Horinouchi M; Shimizu T; Tabata M; Batra SK; Goto M; Yonezawa S
PLoS One; 2012; 7(11):e49251. PubMed ID: 23152882
[TBL] [Abstract][Full Text] [Related]
14. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells.
Ponnusamy MP; Singh AP; Jain M; Chakraborty S; Moniaux N; Batra SK
Br J Cancer; 2008 Aug; 99(3):520-6. PubMed ID: 18665193
[TBL] [Abstract][Full Text] [Related]
15. MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy.
Gautam SK; Kumar S; Dam V; Ghersi D; Jain M; Batra SK
Semin Immunol; 2020 Feb; 47():101391. PubMed ID: 31952903
[TBL] [Abstract][Full Text] [Related]
16. Two novel monoclonal antibodies against the MUC4 tandem repeat reacting with an antigen overexpressed by lung cancer.
Botti C; Seregni E; Ménard S; Collini P; Tagliabue E; Campiglio M; Vergani B; Ghirelli C; Aiello P; Pilotti S; Bombardieri E
Int J Biol Markers; 2000; 15(4):312-20. PubMed ID: 11192827
[TBL] [Abstract][Full Text] [Related]
17. Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating integrin-β1/FAK/ERK pathway.
Jahan R; Macha MA; Rachagani S; Das S; Smith LM; Kaur S; Batra SK
Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2538-2549. PubMed ID: 29777904
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid-dependent transforming growth factor-beta 2-mediated induction of MUC4 mucin expression in human pancreatic tumor cells follows retinoic acid receptor-alpha signaling pathway.
Choudhury A; Singh RK; Moniaux N; El-Metwally TH; Aubert JP; Batra SK
J Biol Chem; 2000 Oct; 275(43):33929-36. PubMed ID: 10938282
[TBL] [Abstract][Full Text] [Related]
19. The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer.
Tang J; Zhu Y; Xie K; Zhang X; Zhi X; Wang W; Li Z; Zhang Q; Wang L; Wang J; Xu Z
J Exp Clin Cancer Res; 2016 Jun; 35(1):91. PubMed ID: 27287498
[TBL] [Abstract][Full Text] [Related]
20. Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas.
Kitazono I; Higashi M; Kitamoto S; Yokoyama S; Horinouchi M; Osako M; Shimizu T; Tabata M; Batra SK; Goto M; Yonezawa S
Pancreas; 2013 Oct; 42(7):1120-8. PubMed ID: 23921963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
